AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN

Completed · Not applicable

Conditions studied: Contrast Induced Nephropathy (CIN)

In brief

The Osprey Medical AVERT System is indicated to reduce contrast media (CM) exposure to the kidneys during percutaneous coronary procedures thereby reducing the risk of contrast induced nephropathy (CIN).

Key facts

Study ID

NCT01976299

Run by

Osprey Medical, Inc

People needed

578

Starts

2013-12-01

Expected to finish

2015-09-01

Last updated by the study team

2017-02-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subject is a candidate for a therapeutic percutaneous coronary intervention (PCI) procedure.
• The subject has documented chronic kidney disease (CKD)

You may not qualify if…

• Subject is in acute renal failure
• Assessment of ventricular function that cannot be accomplished without the use of the CM.
• Subject has acute STEMI within 72 hours prior to planned PCI procedure, or is currently having an acute STEMI.
• Subject is unable to undergo peri-procedural hydration.

Where it is running

• UCSD Medical Center — La Jolla, California, United States
• Long Beach CA VA Hospital — Long Beach, California, United States
• Kaiser Permanente Los Angeles Medical Center — Los Angeles, California, United States
• Stanford Hospital and Clinics — Stanford, California, United States
• Harbor UCLA Medical Center — Torrance, California, United States
• The Heart & Vascular Institute of Florida — Clearwater, Florida, United States
• University of FL College of Medicine - Jacksonville — Jacksonville, Florida, United States
• St. Vincent's Ambulatory Care (dba St. Vincent's Cardiology) — Jacksonville, Florida, United States
• Tallahassee Research Institute, Inc. — Tallahassee, Florida, United States
• Emory University Hospital Midtown — Atlanta, Georgia, United States
• St. Joseph's Hospital (Emory) — Atlanta, Georgia, United States
• Coliseum Medical Center — Macon, Georgia, United States
• University of Illinois at Chicago — Chicago, Illinois, United States
• University of Chicago Medical Center — Chicago, Illinois, United States
• Jewish Hospital — Louisville, Kentucky, United States
• Norton Cardiovascular Associates — Louisville, Kentucky, United States
• Ochsner Clinic Foundation — New Orleans, Louisiana, United States
• Minneapolis Heart Institute Foundation / Abbott Northwestern Hospital — Minneapolis, Minnesota, United States
• Mayo Clinic Hospital, St. Mary's Campus — Rochester, Minnesota, United States
• North Mississippi Medical Center — Tupelo, Mississippi, United States
• Saint Luke's Hospital — Kansas City, Missouri, United States
• Gateway Cardiovascular Research Center, Inc. — St Louis, Missouri, United States
• Mount Sinai Hospital — New York, New York, United States
• LeBauer Cardiovascular Research Foundation — Greensboro, North Carolina, United States
• NC Heart and Vascular Research — Raleigh, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.